The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 No. 704

SCHEDULE 1 CONTROLLED DRUGS TO WHICH SECTION 7(4) OF THE MISUSE OF DRUGS ACT 1971 APPLIES

PART 2 CONTROLLED DRUGS EXCEPTED FROM PART 1

6.  The compounds referred to in paragraph 1(e) are—

• Alfentanil

• Carfentanil

• Lofentanil

• Sufentanil.

7.  The compounds referred to in paragraph 1(f) are—

• Allylprodine

• Alphameprodine

• Alphaprodine

• Anileridine

• Betameprodine

• Betaprodine

• Hydroxypethidine

• Properidine

• Trimeperidine.

8.  The compounds referred to paragraph 1(g) are—

• 1-(3-chlorophenyl)piperazine

• 1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine.

9.  A liquid formulation—

(a) containing a botanical extract of cannabis—

(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and

(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,

(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and

(c) which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on the 16th June 2010.